Vitualla, Erlie May R.

HRN: 23-16-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/18/2023
06/25/2023
IV
600mg
Q8H
Open Fracture Type 1, L Radius And Ulna
Waiting Final Action 
06/18/2023
CEFAZOLIN 1GM (VIAL)
06/18/2023
06/25/2023
IV
500 Mg
Q6h
Open Fracture
Waiting Final Action 
06/18/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
06/18/2023
06/25/2023
TOPICAL
Apply Thinly On Affected Area
TID
Periorbital Hematoma, OS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: